Home068270 • KRX
add
Celltrion Inc
Previous close
₩177,400.00
Day range
₩176,300.00 - ₩178,100.00
Year range
₩131,000.00 - ₩241,000.00
Market cap
38.73T KRW
Avg Volume
562.53K
P/E ratio
47.30
Dividend yield
0.28%
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 382.60B | -25.07% |
Operating expense | 122.78B | 23.59% |
Net income | 1.05B | -98.48% |
Net profit margin | 0.28 | -97.93% |
Earnings per share | — | — |
EBITDA | 91.27B | -42.04% |
Effective tax rate | 104.63% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 757.50B | 27.43% |
Total assets | 19.92T | 238.06% |
Total liabilities | 2.79T | 72.60% |
Total equity | 17.13T | — |
Shares outstanding | 207.21M | — |
Price to book | 2.16 | — |
Return on assets | 0.35% | — |
Return on capital | 0.38% | — |
Cash Flow
Net change in cash
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.05B | -98.48% |
Cash from operations | 149.59B | 71.33% |
Cash from investing | 135.12B | 234.09% |
Cash from financing | -72.69B | -281.02% |
Net change in cash | 203.20B | 634.78% |
Free cash flow | -1.49T | -574.22% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
CEO
Founded
2002
Website
Employees
1,074